business management
In a tough economic environment dominated by increased competition for jobs, minimizing uncertainty has become a key challenge for chief executives.
| 2 min read
Those with strong health, wellness, and safety programs bested S&P 500 average rate of return in investment simulations.
| 2 min read
Bruker Corporation today announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker’s position in life science markets, adding to the Bruker Nano Surfaces Division’s existing life science atomic force microscopy (Bio-AFM) systems.
| 2 min read
Like finding your way through a maze, it can be daunting for businesses to know how to tap into large universities for science and technology skills and solutions. Now, industry has a new way to engage with scientific expertise at Arizona State University’s Biodesign Institute.
| 2 min read
The University of Colorado Boulder today announced the opening of an Office of Industry Collaboration and the naming of Caroline Himes as director.
| 2 min read
VelaLabs, a provider of analytical services to the global biopharmaceutical industry, and Evercyte, a producer of standardized, relevant cell systems, today (Sept. 3) announced that they have entered into a cooperation to commercialize immortalized target cells for the characterization of biosimilars in a GMP environment.
| 1 min read
Chemical inventory management solutions improve compliance and sustainability impact of Accelrys' Scientific Innovation Lifecycle Management portfolio
| 3 min read
Study finds personality is as strong a workplace motivator as external threats or rewards.
| 3 min read
People who are considered unattractive are more likely to be belittled and bullied in the workplace, according to a first-of-its-kind study led by a Michigan State University business scholar.
| 2 min read
The laboratory industry enjoyed several years of robust growth from the late 1990s until 2003. Record research and development (R&D) investments by the biopharmaceutical industry, in combination with the doubling of the U.S. National Institutes budget, allowed for continual double-digit growth rates.
| 5+ min read
